Proangiogenic function of CD40 ligand-CD40 interactions

Journal of Immunology

Volumn 171, Issue 3, 2003, Pages 1534-1541

  Reinders, Marlies E J ^a   Sho, Masayuki ^a   Robertson, Stuart W ^a   Geehan, Christopher S ^a   Briscoe, David M ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; CD40 ANTIGEN; CD40 LIGAND; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SCID MOUSE;

EID: 0042346066     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.3.1534     Document Type: Article

References (56)

1. Cotran, R. S. 1994. Inflammation and repair. In Pathologic Basis of Disease, Chapt. 3. R. S. Cotran, V. Kumar, and S. L. Robbins, eds. Saunders, Philidelphia, pp. 51-92.
2. Brown, L. F., M. Detmar. K. Claffey, J. A. Nagy, D. Feng, A. M. Dvorak, and H. F. Dvorak. 1997. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. EXS 79:233.
3. Folkman, J. 1995. Seminars in Medicine of the Beth Israel Hospital, Boston: clinical applications of research on angiogenesis. N. Engl. J. Med. 333:1757.
4. Carmeliet, P., and R. K. Jain. 2000. Angiogenesis in cancer and other diseases. Nature 407:249,
5. Leung, D. W., G. Cachianes, W. J. Kuang, D. V. Goeddel, and N. Ferrara. 1989. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306.
6. Tischer, E., R. Mitchell, T. Hartman, M. Silva, D. Gospodarowicz, J. C. Fiddes. and J. A. Abraham. 1991. The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266:11947.
7. Polverini, P. J. 1997. Role of the macrophage in angiogenesis-dependent diseases. EXS 79:11.
8. Bottomley, M. J., N. J. Webb, C. J. Watson, P. J. Holt, A. J. Freemont, and P. E. Brenchley. 1999. Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up-regulation by tumour necrosis factor-alpha (TNF-α) in synovial fluid. Clin. Exp. Immunol. 117:171.
9. Freeman, M. R., F. X. Schneck, M. L. Gagnon, C. Corless, S. Soker, K. Niknejad, G. E. Peoples, and M. Klagsbrun. 1995. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res. 55:4140.
10. Peoples, G. E., S. Blotnick, K. Takahashi, M. R. Freeman, M. Klagsbrun, and T. J. Eberlein. 1995. T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role. Proc. Natl. Acad. Sci. USA 92:6547.
11. Ferrara, N. 2000. VEGF: an update on biological and therapeutic aspects. Curr. Opin. Biotechnol. 11:617.
12. Ferrara, N., K. A. Houck, L. B. Jakeman, J. Winer, and D. W. Leung. 1991. The vascular endothelial growth factor family of polypeptides. J. Cell Biochem. 47:211.
13. Zeng, H., H. F. Dvorak, and D. Mukhopadhyay. 2001. Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) receptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways. J. Biol. Chem. 276:26969.
14. Soker, S., S. Takashima, H. Q. Miao, G. Neufeld, and M. Klagsbrun. 1998. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92:735.
15. Carmeliet, P., Y. S. Ng, D. Nuyens, G. Theilmeier, K. Brusselmans, I. Cornelissen, E. Ehler, V. V. Kakkar, I. Stalmans, V. Mattot, et al. 1999. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat. Med. 5:495.
16. Stalmans, I., Y. S. Ng, R. Rohan, M. Fruttiger, A. Bouche, A. Yuce, H. Fujisawa, B. Hermans, M. Shani, S. Jansen, et al. 2002. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J. Clin. Invest. 109:327.
17. Stalmans, I., D. Lambrechts, F. De Smet, S. Jansen, J. Wang, S. Maity, P. Kneer, M. Von Der Ohe, A. Swillen, C. Maes, et al. 2003. VEGF: a modifier of the de122q11 (DiGeorge) syndrome? Nat. Med. 9:173.
18. Pepper, M. S., N. Ferrara, L. Orci, and R. Montesano. 1992. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochim. Biophys. Acta 189:824.
19. Couper, L. L., S. R. Bryant, J. Eldrup-Jorgensen, C. E. Bredenberg, and V. Lindner. 1997. Vascular endothelial growth factor increases the mitogenic response to fibroblast growth factor-2 in vascular smooth muscle cells in vivo via expression of fms-like tyrosine kinase-1. Circ. Res. 81:932.
20. Seghezzi, G., S. Patel, C. J. Ren, A. Gualandris, G. Pintucci, E. S. Robbins, R. L. Shapiro, A. C. Galloway, D. B. Rifkin, and P. Mignatti. 1998. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J. Cell Biol. 141:1659,
21. Alon, T., I. Hemo, A. Itin, J. Pe'er, J. Stone, and E. Keshet. 1995. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med. 1:1024.
22. Sidky, Y. A., and R. Auerbach. 1975. Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs.-host reaction. J. Exp. Med. 141:1084.
23. Polverini, P. J., P. S. Cotran, M. A. Gimbrone, and E. R. Unanue. 1977. Activated macrophages induce vascular proliferation. Nature 269:804.
24. Auerbach, R., and Y. A. Sidky. 1979. Nature of the stimulus leading to lymphocyte-induced angiogenesis. J. Immunol. 123:751.
25. Moulton, K. S., R. J. Melder, V. R. Dharnidharka, J. Hardin-Young, R. K. Jain, and D. M. Briscoe. 1999. Angiogenesis in the huPBL-SCID model of human transplant rejection. Transplantation 67:1626.
26. Leibovich, S. J., P. J. Polverini, H. M. Shepard, D. M. Wiseman, V. Shively, and N. Nuseir. 1987. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α. Nature 329:630.
27. Koch, A. E., P. J. Polverini, and S. J. Leibovich. 1986. Induction of neovascularization by activated human monocytes. J. Leukocyte Biol. 39:233.
28. Wiseman, D. M., P. J. Polverini, D. W. Kamp, and S. J. Leibovich. 1988. Transforming growth factor-β (TGFβ) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochim. Biophys. Acta 157:793.
29. Leibovich, S. J., P. J. Polverini, T. W. Fong, L. A. Harlow, and A. E. Koch. 1994. Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc. Natl. Acad. Sci. USA 91:4190.
30. Yellin, M. J., J. Brett, D. Baum, A. Matsushima, M. Szabolcs, D. Steem, and L. Chess. 1995. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J. Exp. Med. 182:1857.
31. Alderson, M. R., R. J. Armitage, T. W. Tough, L. Strockbine, W. C. Fanslow, and M. K. Spriggs. 1993. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178:669.
32. + T-cell responses. Immunol. Today 17:410.
33. Melter, M., M. E. Reinders, M. Sho, S. Pal, C. Geehan, M. D. Denton, D. Mukhopadhyay, and D. M. Briscoe. 2000. Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. Blood 96:3801.
34. Cho, C. S., M. L. Cho, S. Y. Min, W. U. Kim, D. J. Min, S. S. Lee, S. H. Park, J. Choe, and H. Y. Kim. 2000. CD40 engagement on synovial fibroblast upregulates production of vascular endothelial growth factor. J. Immunol. 164:5055.
35. Tai, Y. T., K. Podar, D. Gupta, B. Lin, G. Young, M. Akiyama, K. C. and Anderson. 2002. CD40 activation induces p53-dependent vascular endothelial growth factor secretion in human multiple myeloma cells. Blood 99:1419.
36. Mach, F., U. Schonbeck, R. P. Fabunmi, C. Murphy, E. Atkinson, J. Y. Bonnefoy, P. Graber, and P. Libby. 1999. T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation. Am. J. Pathol. 154:229.
37. Deregibus, M. C., S. Buttiglieri, S. Russo, B. Bussolati, and G. Camussi. 2002. CD40-dependent activation of phosphatidylinositol 3-kinase/Akt pathway mediates endothelial cell survival and in vitro angiogenesis. J. Biol. Chem. 277:25195.
38. van Kooten, C., X. van der Linde, A. M. Woltman, L. A. van Es, and M. R. Daha. 1999. Synergistic effect of interleukin-1 and CD40L on the activation of human renal tubular epithelial cells. Kidney Int. 56:41.
39. Briscoe, D. M., V. R. Dharnidharka, C. Isaacs, G. Downing, S. Prosky, P. Shaw, N. L. Parenteau, and J. Hardin-Young. 1999. The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejecton. Transplantation 67:1590.
40. Weidner, N., J. P. Semple, W. R. Welch, and J. Folkman. 1991. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N. Engl. J. Med. 324:1.
41. Ng, Y. S., and P. A. D'Amore. 2001. Therapeutic angiogenesis for cardiovascular disease. Curr. Control Trials Cardiovasc. Med. 2:278.
42. Folkman, J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:27.
43. Celletti, F. L., J. M. Waugh, P. G. Amabile, A. Brendolan, P. R. Hilfiker, and M. D. Dake. 2001. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat. Med. 7:425.
44. Lu, J., T. Kasama, K. Kobayashi, Y. Yoda, F. Shiozawa, M. Hanyuda, M. Negishi, H. Ide, and M. Adachi. 2000. Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis. J. Immunol. 164:5922.
45. Denton, M. D., R. M. Reul, V. R. Dharnidharka, J. C. Fang, P. Ganz, and D. M. Briscoe. 1998. Central role for CD40/CD40 ligand (CD154) interactions in transplant rejection. Pediatr. Transplant. 2:6.
46. Van Kooten, C., and J. Banchereau. 1996. CD40-CD40-ligand: a multifunctional receptor-ligand pair. Adv. Immunol. 61:1.
47. Mach, F., U. Schonbeck, J. Y. Bonnefoy, J. S. Pober, and P. Libby. 1997. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 96:396.
48. Urbich, C., E. Dernbach, A. Aicher, A. M. Zeiher, and S. Dimmeler. 2002. CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species. Circulation 106:9816.
49. Mach, F., U. Schonbeck, and P. Libby. 1998. CD40 signaling in vascular cells: a key role in atherosclerosis? Atherosclerosis 137(Suppl.):S89.
50. Reul, R. M., J. C. Fang, M. D. Denton, C. Geehan, C. Long, R. N. Mitchell, P. Ganz, and D. M. Briscoe. 1997. CD40 and CD40 ligand (CD154) are coexpressed on microvessels in vivo in human cardiac allograft rejection. Transplantation 64:1765.
51. Hansson, G. K., P. Libby, U. Schonbeck, and Z. Q. Yan. 2002. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ. Res. 91:281.
52. Larsen, C. P., D. Z. Alexander, D. Hollenbaugh, E. T. Elwood, S. C. Ritchie, A. Aruffo, R. Hendrix, and T. C. Pearson. 1996. CD40-gp39 interactions play a critical role during allograft rejection. Transplantation 61:4.
53. Larsen, C. P., E. T. Elwood, D. Z. Alexander, S. C. Ritchie, R. Hendrix, C. Tucker-Burden, H. R. Cho, A. Aruffo, D. Hollenbaugh, P. S. Linsley, et al. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381:434.
54. Hancock, W. W., M. H. Sayegh, X. G. Zheng, R. Peach, P. S. Linsley, and L. A. Turka. 1996. Costimulatory function and expresson of CD40 ligand, CD80, CD86 in vascularized murine cardiac allograft rejection. Proc, Natl. Acad. Sci. USA 93:13967.
55. Kirk, A. D., D. M. Harlan, N. N. Armstrong, T. A. Davis, Y. Dong, G. S. Gray, X. Hong, D. Thomas, J. H. Fechner, Jr., and S. J. Knechtle. 1997. CTLA4-Ig and anti CD40 ligand prevent renal allograft rejection in primates. Proc. Natl. Acad. Sci. USA 94:8789.
56. Schonbeck, U., G. K. Sukhova, K. Shimizu, F. Mach, and P. Libby. 2000. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. Proc. Natl. Acad. Sci. USA 97:7458.